Rheumatoid Arthritis Research Today is a free monthly online journal that collates and summarizes the latest research about Rheumatoid Arthritis, including details on treatment, symptoms, causes, medication.

Volume 3 (2006), Issue 3 (March)

1. The impact on health-related quality of life from non-steroidal anti-inflammatory drugs, methotrexate, or steroids in treatment for juvenile idiopathic arthritis.
   J Pediatr Psychol, 31(3): 262-71. [Abstract] [Full-text]
2. Methotrexate modulates the kinetics of adenosine in humans in vivo.
   Ann Rheum Dis, 65(4): 465-70. [Abstract] [Full-text]
3. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
   Ann Rheum Dis, 65(4): 453-8. [Abstract] [Full-text]
4. Assessment of the clinical significance of gelatinase activity in patients with juvenile idiopathic arthritis using quantitative protein substrate zymography.
   Ann Rheum Dis, 65(4): 501-7. [Abstract] [Full-text]
5. An open label, single dose study to evaluate the safety, efficacy, and effects on CD25 expression of ciclosporin in patients with active rheumatoid arthritis despite treatment with methotrexate and infliximab.
   Ann Rheum Dis, 65(4): 538-41. [Abstract] [Full-text]
6. Use of digital x ray radiogrammetry in the assessment of joint damage in rheumatoid arthritis.
   Ann Rheum Dis, 65(4): 459-64. [Abstract] [Full-text]
7. Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS/EULAR management recommendations in ankylosing spondylitis.
   Ann Rheum Dis, 65(4): 423-32. [Abstract] [Full-text]
8. ASAS/EULAR recommendations for the management of ankylosing spondylitis.
   Ann Rheum Dis, 65(4): 442-52. [Abstract] [Full-text]
9. Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis.
   Ann Rheum Dis, 65(4): 535-7. [Abstract] [Full-text]
10. Orbital cellulitis in a patient receiving infliximab for Ankylosing spondylitis.
    Am J Ophthalmol, 141(4): 767-9. [Abstract] [Full-text]
11. The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work.
    Med Care, 44(4): 304-10. [Abstract] [Full-text]
12. Prospective study of survival outcomes in Non-Hodgkin's lymphoma patients with rheumatoid arthritis.
    J Clin Oncol, 24(10): 1597-602. [Abstract] [Full-text]

© 2004-2010 Rheumatoid Arthritis Research Today. All Rights Reserved.